Medtronic PLC operates within the Electromedical equipment sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medtronic PLC with three other
medical equipment manufacturers in North America:
sales of $3.11 billion
of which 63%
of which 38%
was Plasma), and
of which 88%
was Sleep and Respiratory Care).
During the third
quarter of 2021, sales at Medtronic PLC totalled
an increase of 22.7%
from the $6.51 billion in sales at the company during the third quarter of 2020.
During the first three quarters of 2021, sales totalled $23.95 billion, which is
than through the first three
quarters of 2020.
There appears to be at least some degree of seasonality in the sales at Medtronic PLC: during 7 of the previous 8
years, sales were highest during the second quarter.
The exception to this was during 2020, when the
first quarter was the best quarter, accounting for
28% of sales (during that same year, the
second quarter accounted for 22% of sales).
During the year ended April of 2021, sales at
Medtronic PLC were $30.12 billion.
increase of 4.2%
versus 2020, when the company's sales were $28.91 billion.
Despite this increase, sales are still
below the level achieved in 2019, when Medtronic PLC
reported sales of $30.56 billion.
The sales level in 2021 was fairly close to the level five years ago: in 2016, Medtronic PLC had sales
of $28.83 billion.
Sales of Restorative Therapies Group saw an increase
6.1% in 2021, from
$7.73 billion to $8.20 billion.